Reduced Ribavirin Antiviral Efficacy via Nucleoside Transporter-Mediated Drug Resistance - Test2 - elhamkhani - TriplyDB

Reduced Ribavirin Antiviral Efficacy via Nucleoside Transporter-Mediated Drug Resistance

Reduced Ribavirin Antiviral Efficacy via Nucleoside Transporter-Mediated Drug Resistance

http://www.wikidata.org/entity/Q27488307

about

Resistance of Hepatitis C Virus to Inhibitors: Complexity and Clinical Implications Plasma membrane transporters in modern liver pharmacology Cell type mediated resistance of vesicular stomatitis virus and Sendai virus to ribavirin Coronaviruses lacking exoribonuclease activity are susceptible to lethal mutagenesis: evidence for proofreading and potential therapeutics Host-based ribavirin resistance influences hepatitis C virus replication and treatment response.Antiviral activity and possible mechanism of action of constituents identified in Paeonia lactiflora root toward human rhinoviruses.Isolation of fidelity variants of RNA viruses and characterization of virus mutation frequency.Establishment of hepatitis C virus RNA-replicating cell lines possessing ribavirin-resistant phenotype.Lack of the nucleoside transporter ENT1 results in the Augustine-null blood type and ectopic mineralization.Ribavirin Contributes to Hepatitis C Virus Suppression by Augmenting pDC Activation and Type 1 IFN Production Ribavirin potentiates interferon action by augmenting interferon-stimulated gene induction in hepatitis C virus cell culture models HCV infection selectively impairs type I but not type III IFN signaling.Role of ribavirin in HCV treatment response: now and in the future.Plaques Formed by Mutagenized Viral Populations Have Elevated Coinfection Frequencies.Basic answers to complicated questions for the course of chronic hepatitis C treatment.Persistent hepatitis C virus infection impairs ribavirin antiviral activity through clathrin-mediated trafficking of equilibrative nucleoside transporter 1.Selection of hepatitis C virus resistant to ribavirin.Equilibrative Nucleoside Transporters 1 and 4: Which One Is a Better Target for Cardioprotection Against Ischemia-Reperfusion Injury?Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses.Endotoxin-Mediated Downregulation of Hepatic Drug Transporters in HIV-1 Transgenic Rats.Single and combined IL28B, ITPA and SLC28A3 host genetic markers modulating response to anti-hepatitis C therapy.Middle East Respiratory Syndrome and Severe Acute Respiratory Syndrome: Current Therapeutic Options and Potential Targets for Novel Therapies.Quasispecies and Drug Resistance

P2860

Q26777408-C16DEDFA-D409-43F9-9100-D947A356E611 Q26829263-865E8538-A8CD-4A84-A3E6-305CBB3B22A7 Q28474617-1CE71055-2A9E-4C76-B7BB-BB80D3D1B6A9 Q28535361-86A210C0-A05A-45BB-B175-B734D5F32DE2 Q35077712-DCCA917E-2FFB-456B-8374-347C4B56FA11 Q35362286-CC27DBAA-D040-4FE1-BB07-F12AD2ACA74A Q35391721-8DBAF9B4-A51D-49EA-9990-343972B5B405 Q35564506-070F8CBB-0647-462E-A739-C4D2F4BE97E1 Q35692423-B598659C-E4DD-43F0-A4DC-9F19DC3CF5E4 Q35746343-1EC2EFC6-A00C-4503-8721-EA42C53C0540 Q36399860-0B1CDB77-7678-43AC-B629-B0617B9EB269 Q37415444-98F01C8B-89F3-45EF-9931-203A6AEB4315 Q37693948-4AEBCAB9-C2EF-4398-891F-9769791DF959 Q37700069-E1E6F439-C0E7-4B22-BE03-906A2CDD91D9 Q38014499-9A6D3654-8014-4E21-8F9E-9B2D648EDD9D Q38262107-071C11C3-CAF9-4132-9C21-BF35593B13FD Q38269623-7883F5CA-ACB2-44F7-A4CF-B9ED119E23D1 Q38526404-4D75131A-C5D7-488D-9F62-B95B9B6239D0 Q38665457-9E120EC6-183A-4C7C-AD9D-5E87153EEA8E Q40755393-D857D864-86A7-42DE-ADE3-057F74CF5983 Q43048075-19A6D436-F27E-48FF-82C1-EF35E7EDB426 Q43280688-71503398-917F-446F-B62E-967AB4416693 Q56957250-CB42B965-FE3C-4FCC-B37C-BC1FA7A1D004

P2860

Reduced Ribavirin Antiviral Efficacy via Nucleoside Transporter-Mediated Drug Resistance

http://www.wikidata.org/entity/Q27488307

description

2009 nî lūn-bûn

@nan

2009 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Reduced Ribavirin Antiviral Efficacy via Nucleoside Transporter-Mediated Drug Resistance

@ast

Reduced Ribavirin Antiviral Efficacy via Nucleoside Transporter-Mediated Drug Resistance

@en

Reduced Ribavirin Antiviral Efficacy via Nucleoside Transporter-Mediated Drug Resistance

@nl

type

label

Reduced Ribavirin Antiviral Efficacy via Nucleoside Transporter-Mediated Drug Resistance

@ast

Reduced Ribavirin Antiviral Efficacy via Nucleoside Transporter-Mediated Drug Resistance

@en

Reduced Ribavirin Antiviral Efficacy via Nucleoside Transporter-Mediated Drug Resistance

@nl

prefLabel

Reduced Ribavirin Antiviral Efficacy via Nucleoside Transporter-Mediated Drug Resistance

@ast

Reduced Ribavirin Antiviral Efficacy via Nucleoside Transporter-Mediated Drug Resistance

@en

Reduced Ribavirin Antiviral Efficacy via Nucleoside Transporter-Mediated Drug Resistance

@nl

P1433

Q27488307-718AA49E-654E-4EC4-93DD-4821B3298758

P1476

Q27488307-DF8FE054-7E2D-4280-890B-8D2DC1E9BE02

P2093

Q27488307-328F59AB-9912-424D-85B5-9BDAF2B9B9D0

Q27488307-9E7D48BB-932D-4704-96F0-579B11E54FD1

P2860

Q27488307-0BA2E94A-8A15-4262-B530-61077433F99C

Q27488307-0C32DCE5-4CB9-45D1-B47D-A806EDF102AB

Q27488307-124B04B0-0FEE-4CF3-B248-5CFD2C8F4874

Q27488307-154C2324-2D7D-49EF-9342-C804984D3642

Q27488307-1653F331-9933-457D-B1CC-014ECFAB8652

Q27488307-1773A364-B215-4DD0-B2BD-0CB1D4174A87

Q27488307-19E9C18C-8317-4A68-BF02-237D6DD43088

Q27488307-1C671DD6-C490-4711-9A3C-0EEBCE635970

Q27488307-1FC694DB-713C-4ECE-B7E5-8829AB758051

Q27488307-20925803-8005-4490-962C-E456D50FAD93

P304

Q27488307-CC621C3B-C1B7-423F-899E-3F8664749CAC

P31

Q27488307-AD2B6EFF-23B0-44E5-83A4-D560481A4134

P356

Q27488307-3025888B-FDBC-49D0-81E9-11A687F14719

P433

Q27488307-00B10798-9480-4491-AB5A-5BC7E2B1C9B1

P478

Q27488307-282FA332-7B4A-4C8B-AB8A-8D5EDAE2B721

P577

Q27488307-C1FF9A72-D9FC-459E-9FE4-99DF2F1F5281

P698

Q27488307-515F99B4-10D1-4D29-91F1-3D3C566D737B

P932

Q27488307-45406A20-905B-4428-A1B1-2838582DFC2F

P356

P1433

Journal of Virology

P1476

Reduced Ribavirin Antiviral Efficacy via Nucleoside Transporter-Mediated Drug Resistance

@en

P2093

Julie K Pfeiffer

http://www.w3.org/2001/XMLSchema#string

Kristie D Ibarra

http://www.w3.org/2001/XMLSchema#string

P2860

RNA virus error catastrophe: direct molecular test by using ribavirin

Molecular cloning of poliovirus cDNA and determination of the complete nucleotide sequence of the viral genome

Resistance to gemcitabine in a human follicular lymphoma cell line is due to partial deletion of the deoxycytidine kinase gene

Ribavirin Quantification in Combination Treatment of Chronic Hepatitis C

Viral Determinants of Resistance to Treatment in Patients with Hepatitis C

Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region

Primer3 on the WWW for general users and for biologist programmers

The equilibrative nucleoside transporter family, SLC29

The concentrative nucleoside transporter family, SLC28

Fludarabine uptake mechanisms in B-cell chronic lymphocytic leukemia

P304

4538-47

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.02280-08

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

83

http://www.w3.org/2001/XMLSchema#string

P577

2009-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19244331

http://www.w3.org/2001/XMLSchema#string

P932

2668478

http://www.w3.org/2001/XMLSchema#string